These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17881774)

  • 41. Nine novel pathogenic germline mutations in MLH1, MSH2, MSH6 and PMS2 in families with Lynch syndrome.
    Rahner N; Friedrichs N; Wehner M; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C
    Acta Oncol; 2007; 46(6):763-9. PubMed ID: 17653898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple mutations are common at mouse Aprt in genotoxin-exposed mismatch repair deficient cells.
    Shin CY; Mellon I; Turker MS
    Oncogene; 2002 Mar; 21(11):1768-76. PubMed ID: 11896608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer.
    Nyström-Lahti M; Perrera C; Räschle M; Panyushkina-Seiler E; Marra G; Curci A; Quaresima B; Costanzo F; D'Urso M; Venuta S; Jiricny J
    Genes Chromosomes Cancer; 2002 Feb; 33(2):160-7. PubMed ID: 11793442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cisplatin represses transcriptional activity from the minimal promoter of the O6-methylguanine methyltransferase gene and increases sensitivity of human gallbladder cancer cells to 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-2-chloroethyl)-3-nitrosourea.
    Sato K; Kitajima Y; Nakagawachi T; Soejima H; Miyoshi A; Koga Y; Miyazaki K
    Oncol Rep; 2005 May; 13(5):899-906. PubMed ID: 15809756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements.
    Chen J; Sadowski I
    Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4813-8. PubMed ID: 15781865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer.
    Amatu A; Sartore-Bianchi A; Moutinho C; Belotti A; Bencardino K; Chirico G; Cassingena A; Rusconi F; Esposito A; Nichelatti M; Esteller M; Siena S
    Clin Cancer Res; 2013 Apr; 19(8):2265-72. PubMed ID: 23422094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features.
    Belvederesi L; Bianchi F; Loretelli C; Gagliardini D; Galizia E; Bracci R; Rosati S; Bearzi I; Viel A; Cellerino R; Porfiri E
    Eur J Hum Genet; 2006 Jul; 14(7):853-9. PubMed ID: 16724012
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transfer and expression of human O6-methylguanine-DNA methyltransferase cDNA confers resistance of Mer- HeLa MR cells to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a.
    Yang J; Chen JM; Zhang YP
    Carcinogenesis; 1995 Sep; 16(9):2271-4. PubMed ID: 7554090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Study on potentiation of nitrosourea-cytotoxicity by DNA repair enzyme inhibitors in human brain tumor cells].
    Fukuchi M; Mineura K; Kowada M; Terashima I; Kohda K
    No To Shinkei; 1997 Jun; 49(6):521-8. PubMed ID: 9198092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apoptotic function of human PMS2 compromised by the nonsynonymous single-nucleotide polymorphic variant R20Q.
    Marinovic-Terzic I; Yoshioka-Yamashita A; Shimodaira H; Avdievich E; Hunton IC; Kolodner RD; Edelmann W; Wang JY
    Proc Natl Acad Sci U S A; 2008 Sep; 105(37):13993-8. PubMed ID: 18768816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mismatch repair and treatment resistance in ovarian cancer.
    Helleman J; van Staveren IL; Dinjens WN; van Kuijk PF; Ritstier K; Ewing PC; van der Burg ME; Stoter G; Berns EM
    BMC Cancer; 2006 Jul; 6():201. PubMed ID: 16879751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas.
    Ueda S; Mineta T; Nakahara Y; Okamoto H; Shiraishi T; Tabuchi K
    J Neurosurg; 2004 Oct; 101(4):659-63. PubMed ID: 15481722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. O6-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glioma therapies.
    Sasai K; Akagi T; Aoyanagi E; Tabu K; Kaneko S; Tanaka S
    Mol Cancer; 2007 Jun; 6():36. PubMed ID: 17547775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mlh1 can function in antibody class switch recombination independently of Msh2.
    Schrader CE; Vardo J; Stavnezer J
    J Exp Med; 2003 May; 197(10):1377-83. PubMed ID: 12743174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meiotic arrest and aneuploidy in MLH3-deficient mice.
    Lipkin SM; Moens PB; Wang V; Lenzi M; Shanmugarajah D; Gilgeous A; Thomas J; Cheng J; Touchman JW; Green ED; Schwartzberg P; Collins FS; Cohen PE
    Nat Genet; 2002 Aug; 31(4):385-90. PubMed ID: 12091911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms.
    Yuan ZQ; Gottlieb B; Beitel LK; Wong N; Gordon PH; Wang Q; Puisieux A; Foulkes WD; Trifiro M
    Hum Mutat; 2002 Feb; 19(2):108-13. PubMed ID: 11793469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a new application of the comet assay to assess levels of O6-methylguanine in genomic DNA (CoMeth).
    Ramos AA; Pedro DF; Lima CF; Collins AR; Pereira-Wilson C
    Free Radic Biol Med; 2013 Jul; 60():41-8. PubMed ID: 23391575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The MLH1 variants p.Arg265Cys and p.Lys618Ala affect protein stability while p.Leu749Gln affects heterodimer formation.
    Perera S; Bapat B
    Hum Mutat; 2008 Feb; 29(2):332. PubMed ID: 18205192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice.
    Kawate H; Itoh R; Sakumi K; Nakabeppu Y; Tsuzuki T; Ide F; Ishikawa T; Noda T; Nawata H; Sekiguchi M
    Carcinogenesis; 2000 Feb; 21(2):301-5. PubMed ID: 10657972
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of the excision step in human DNA mismatch repair.
    Genschel J; Modrich P
    Methods Enzymol; 2006; 408():273-84. PubMed ID: 16793375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.